Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.21 | -23.37 |
| PEG Ratio (TTM) | 0.00 | -7.10 |
| P/S Ratio (TTM) | 4.09 | 44.34 |
| P/B Ratio (TTM) | 0.18 | 33.03 |
| P/FCF Ratio (TTM) | -0.27 | -7.73 |
| Price to 5YR AVG Earnings Ratio | N/A | -7.08 |
| Price to 5YR AVG FCF Ratio | N/A | -13.02 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -84.64% | -15.67% |
| ROE (TTM) | -81.66% | 27.44% |
| Net Profit Margin (TTM) | -1,615.79% | -627.99% |
| ROIC 5YR AVG | N/A | -4.84% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.73% | -1,181.97% | N/A |
| Revenue | -25.00% | 1,010.13% | N/A |
| Net Income | 1.51% | -1,909.13% | N/A |
| Cash Flow | -6.49% | -2,818.34% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 14.81 | 5.66 |
| Quick Ratio (TTM) | 14.81 | 5.44 |
| D/E Ratio (TTM) | N/A | 1.19 |
| Interest Coverage (TTM) | N/A | -5.92 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | N/A | 13.21 |
| LTL to 5YR AVG FCF | N/A | 0.09 |
| Shares Outstanding Growth 5YR AVG | N/A | 39.51% |